Russo, V., Carbone, A., Mottola, F. F., Mocerino, R., Verde, R., Attena, E., . . . Severino, S. (2020). Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients. Front Pharmacol.
Stile di citazione ChicagoRusso, Vincenzo, et al. "Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine On QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients." Front Pharmacol 2020.
Citazione MLARusso, Vincenzo, et al. "Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine On QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients." Front Pharmacol 2020.